Sailong Pharmaceutical: Announcement on stock price changes
Sailong Pharmaceutical: Announcement on Subsidiaries Obtaining Approval Notice for Chemical Raw Material Marketing Applications
Sailong Pharmaceutical: Announcement on Subsidiaries Obtaining Approval Notice for Chemical Raw Material Marketing Applications
Sailong Pharmaceutical: Explanation of the Board of Directors and Audit Committee on the reasonableness of the company\'s impairment preparations
Sailong Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Cailong Pharmaceuticals: Announcement on Accepting Subsidiary Guarantees
Sailong Pharmaceutical: Semi-Annual Report Board Resolution Announcement
Cailong Pharmaceuticals: 2024 Semi-Annual Financial Report
Sailong Pharmaceutical: Announcement on the company\'s application for credit from the bank and the actual controller providing a guarantee
Sailong Pharmaceutical: Review Opinions of the 2nd Meeting of the Fourth Board Audit Committee in 2024
Sailong Pharmaceutical: Announcement on changing the company\'s business scope and amending the “Articles of Association”
Cailong Pharmaceuticals: Articles of Association (August 2024)
Cailong Pharmaceuticals: Amendments to the Articles of Association
Sailong Pharmaceutical: Semi-Annual Report Supervisory Board Resolutions Announcement
Sailong Pharmaceutical: Announcement on renewing the Company\'s 2024 Audit Institution
Sailong Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Sailong Pharmaceutical: Explanation of the Supervisory Board on the reasonableness of the company\'s impairment preparations
Cailong Pharmaceuticals: 2024 Semi-Annual Report Summary
Sailong Pharmaceutical: Review Opinions of the 2nd Meeting of the 4th Special Meeting of Independent Directors of the Board of Directors in 2024
Cailong Pharmaceuticals: Semi-Annual Report 2024
No Data
No Data